Onoue S - Search Results

1

Development of inhalable nanocrystalline solid dispersion of tranilast for airway inflammatory diseases.

Onoue S, Aoki Y, Kawabata Y, Matsui T, Yamamoto K, Sato H, Yamauchi Y, Yamada S. Onoue S, et al. J Pharm Sci. 2011 Feb;100(2):622-33. doi: 10.1002/jps.22299. J Pharm Sci. 2011. PMID: 20653048

2

Structure-activity relationship of synthetic truncated analogues of vasoactive intestinal peptide (VIP): an enhancement in the activity by a substitution with arginine.

Onoue S, Ohmori Y, Matsumoto A, Yamada S, Kimura R, Yajima T, Kashimoto K. Onoue S, et al. Life Sci. 2004 Feb 6;74(12):1465-77. doi: 10.1016/j.lfs.2003.07.048. Life Sci. 2004. PMID: 14729396

3

Alpha-helical structure in the C-terminus of vasoactive intestinal peptide: functional and structural consequences.

Onoue S, Matsumoto A, Nagano Y, Ohshima K, Ohmori Y, Yamada S, Kimura R, Yajima T, Kashimoto K. Onoue S, et al. Eur J Pharmacol. 2004 Feb 6;485(1-3):307-16. doi: 10.1016/j.ejphar.2003.11.046. Eur J Pharmacol. 2004. PMID: 14757155

4

Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide attenuate the cigarette smoke extract-induced apoptotic death of rat alveolar L2 cells.

Onoue S, Ohmori Y, Endo K, Yamada S, Kimura R, Yajima T. Onoue S, et al. Eur J Biochem. 2004 May;271(9):1757-67. doi: 10.1111/j.1432-1033.2004.04086.x. Eur J Biochem. 2004. PMID: 15096214 Free article.

5

Long-acting analogue of vasoactive intestinal peptide, [R15, 20, 21, L17]-VIP-GRR (IK312532), protects rat alveolar L2 cells from the cytotoxicity of cigarette smoke.

Onoue S, Endo K, Ohmori Y, Yamada S, Kimura R, Yajima T, Kashimoto K. Onoue S, et al. Regul Pept. 2004 Dec 15;123(1-3):193-9. doi: 10.1016/j.regpep.2004.04.025. Regul Pept. 2004. PMID: 15518912

6

Pharmacological effects and lung-binding characteristics of a novel VIP analogue, [R15, 20, 21, L17]-VIP-GRR (IK312532).

Ohmori Y, Maruyama S, Kimura R, Onoue S, Matsumoto A, Endo K, Iwanaga T, Kashimoto K, Yamada S. Ohmori Y, et al. Among authors: onoue s. Regul Pept. 2004 Dec 15;123(1-3):201-7. doi: 10.1016/j.regpep.2004.04.029. Regul Pept. 2004. PMID: 15518913

7

Development of dry powder inhalation system of novel vasoactive intestinal peptide (VIP) analogue for pulmonary administration.

Ohmori Y, Onoue S, Endo K, Matsumoto A, Uchida S, Yamada S. Ohmori Y, et al. Among authors: onoue s. Life Sci. 2006 Jun 6;79(2):138-43. doi: 10.1016/j.lfs.2005.12.049. Epub 2006 Feb 3. Life Sci. 2006. PMID: 16458931

8

Bioactive analogues and drug delivery systems of vasoactive intestinal peptide (VIP) for the treatment of asthma/COPD.

Onoue S, Yamada S, Yajima T. Onoue S, et al. Peptides. 2007 Sep;28(9):1640-50. doi: 10.1016/j.peptides.2007.04.009. Epub 2007 Apr 22. Peptides. 2007. PMID: 17537541 Review.

9

Analytical studies on photochemical behavior of phototoxic substances; effect of detergent additives on singlet oxygen generation.

Onoue S, Yamauchi Y, Kojima T, Igarashi N, Tsuda Y. Onoue S, et al. Pharm Res. 2008 Apr;25(4):861-8. doi: 10.1007/s11095-007-9383-4. Epub 2007 Aug 1. Pharm Res. 2008. PMID: 17668299

10

Solid form selection of zwitterionic 5-HT4 receptor agonist.

Kojima T, Sugano K, Onoue S, Murase N, Sato M, Kawabata Y, Mano T. Kojima T, et al. Among authors: onoue s. Int J Pharm. 2008 Feb 28;350(1-2):35-42. doi: 10.1016/j.ijpharm.2007.08.026. Epub 2007 Aug 24. Int J Pharm. 2008. PMID: 17919860

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

265 results

Search Page

Filters